Provided by Tiger Fintech (Singapore) Pte. Ltd.

IMMUNOTECH-B

4.010
+0.0501.26%
Volume:761.00K
Turnover:3.06M
Market Cap:2.06B
PE:-10.10
High:4.150
Open:4.000
Low:3.950
Close:3.960
Loading ...

Company Profile

Company Name:
IMMUNOTECH-B
Exchange:
SEHK
Establishment Date:
2006
Employees:
154
Office Location:
Guosheng Technology Park,8th Floor, Block 1,No.1 Kangding Street,Beijing Eco-Tech Dev Area,Beijing,China
Zip Code:
- -
Phone:
- -
Fax:
86 10 8840 0152
Introduction:
Immunotech Biopharm Ltd is a China-based investment holding company mainly engaged in the research and development, manufacturing and commercialization of immune cell products for treatments of cancers. Its main products are EAL, CAR-T cell series and TCR-T cell series products. EAL is a multi-target cellular immunotherapy product. It also provides cell cryopreservation services. The Company mainly conducts its businesses in the domestic market.

Directors

Name
Position
TAN Zheng
Chairman of the Board,Executive Director,Chairman of the Nomination Committee
WANG Ying Dian
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Member
CHI KIT NG
Independent Director,Member of the Remuneration and Assessment Committee,Audit Committee Chairman
PENG Su Jiu
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee
ZHANG Guo Guang
Independent Director
WANG Rui Hua
Director
YANG Fan
Director
WANG Dong Hu
Director
YU Xiao Hui
Director,Audit Committee Member
YANG Xin
Director
LIU Rui
Director

Shareholders

Name
Position
ZHANG Jian
Acting CEO,Vice General Manager
LIANG Rui Bing
Corporate Secretary
ZHENG Xuan Zhe
Other Senior Executives